CellProthera SAS
www.cellprothera.comCellProthera, a biotechnological company, has developed a unique therapeutic technique which enables the structural and functional regeneration of severe post-infarctus cardiac lesions. After European and national (FR/GB) authorization was obtained , CellProthera has started its I/IIB clinical trial in Humans.
Read more
CellProthera, a biotechnological company, has developed a unique therapeutic technique which enables the structural and functional regeneration of severe post-infarctus cardiac lesions. After European and national (FR/GB) authorization was obtained , CellProthera has started its I/IIB clinical trial in Humans.
Read more
Country
City (Headquarters)
Mulhouse
Industry
Employees
11-50
Founded
2008
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Group Financial Director
Email ****** @****.comPhone (***) ****-****Administrative Manager Laboratory of Medico - Surgical Anatomy
Email ****** @****.comPhone (***) ****-****Administrative Manager , Rh&Com at Cellprothera
Email ****** @****.comPhone (***) ****-****
Technologies
(9)
Reach decision makers at CellProthera SAS
Free credits every month!
CellProthera SAS FAQ
Mulhouse, France
Biotechnology Research
